Goldman Sachs’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $501M | Buy |
2,371,854
+320,121
| +16% | +$68.9M | 0.06% | 348 |
|
|
2025
Q4 | $422M | Buy |
2,051,733
+74,119
| +4% | +$13.9M | 0.05% | 358 |
|
|
2025
Q3 | $310M | Buy |
1,977,614
+378,137
| +24% | +$58.4M | 0.04% | 456 |
|
|
2025
Q2 | $269M | Buy |
1,599,477
+176,660
| +12% | +$26.2M | 0.04% | 465 |
|
|
2025
Q1 | $196M | Sell |
1,422,817
-36,610
| -3% | -$4.67M | 0.03% | 518 |
|
|
2024
Q4 | $173M | Buy |
1,459,427
+343,417
| +31% | +$40.1M | 0.03% | 559 |
|
|
2024
Q3 | $123M | Buy |
1,116,010
+203,658
| +22% | +$21.3M | 0.02% | 709 |
|
|
2024
Q2 | $89.7M | Buy |
912,352
+26,067
| +3% | +$2.66M | 0.02% | 852 |
|
|
2024
Q1 | $99.2M | Sell |
886,285
-390,538
| -31% | -$42.1M | 0.02% | 788 |
|
|
2023
Q4 | $129M | Buy |
1,276,823
+48,158
| +4% | +$4.78M | 0.02% | 651 |
|
|
2023
Q3 | $107M | Sell |
1,228,665
-137,713
| -10% | -$12.4M | 0.02% | 684 |
|
|
2023
Q2 | $129M | Sell |
1,366,378
-263,550
| -16% | -$22.3M | 0.03% | 607 |
|
|
2023
Q1 | $123M | Sell |
1,629,928
-331,237
| -17% | -$25M | 0.03% | 600 |
|
|
2022
Q4 | $151M | Buy |
1,961,165
+562,270
| +40% | +$42.7M | 0.04% | 528 |
|
|
2022
Q3 | $93.3M | Sell |
1,398,895
-192,035
| -12% | -$12.2M | 0.02% | 718 |
|
|
2022
Q2 | $83.2M | Buy |
1,590,930
+397,279
| +33% | +$22.6M | 0.02% | 801 |
|
|
2022
Q1 | $67.7M | Sell |
1,193,651
-74,270
| -6% | -$3.98M | 0.01% | 1038 |
|
|
2021
Q4 | $65.3M | Buy |
1,267,921
+82,833
| +7% | +$4.06M | 0.01% | 1127 |
|
|
2021
Q3 | $58.6M | Buy |
1,185,088
+99,886
| +9% | +$5.42M | 0.01% | 1165 |
|
|
2021
Q2 | $62M | Buy |
1,085,202
+8,668
| +0.8% | +$506K | 0.01% | 1088 |
|
|
2021
Q1 | $65.4M | Sell |
1,076,534
-112,499
| -9% | -$6.21M | 0.02% | 947 |
|
|
2020
Q4 | $63.7M | Buy |
1,189,033
+133,570
| +13% | +$6.93M | 0.02% | 929 |
|
|
2020
Q3 | $49.6M | Sell |
1,055,463
-482,921
| -31% | -$24.8M | 0.01% | 1009 |
|
|
2020
Q2 | $80.3M | Sell |
1,538,384
-177,923
| -10% | -$9.17M | 0.02% | 649 |
|
|
2020
Q1 | $82.3M | Sell |
1,716,307
-1,066,060
| -38% | -$55.4M | 0.03% | 592 |
|
|
2019
Q4 | $141M | Buy |
2,782,367
+153,904
| +6% | +$7.95M | 0.04% | 526 |
|
|
2019
Q3 | $124M | Buy |
2,628,463
+247,700
| +10% | +$11.3M | 0.04% | 538 |
|
|
2019
Q2 | $112M | Buy |
2,380,763
+326,192
| +16% | +$15M | 0.03% | 600 |
|
|
2019
Q1 | $98.9M | Buy |
2,054,571
+40,428
| +2% | +$2.03M | 0.03% | 670 |
|
|
2018
Q4 | $89.8M | Sell |
2,014,143
-619,719
| -24% | -$32.3M | 0.03% | 670 |
|
|
2018
Q3 | $142M | Buy |
2,633,862
+213,274
| +9% | +$10.9M | 0.04% | 554 |
|
|
2018
Q2 | $118M | Buy |
2,420,588
+229,584
| +10% | +$13M | 0.03% | 633 |
|
|
2018
Q1 | $137M | Buy |
2,191,004
+507,618
| +30% | +$34.8M | 0.04% | 599 |
|
|
2017
Q4 | $103M | Sell |
1,683,386
-659,060
| -28% | -$40.7M | 0.02% | 777 |
|
|
2017
Q3 | $157M | Sell |
2,342,446
-14,903
| -0.6% | -$1.05M | 0.04% | 546 |
|
|
2017
Q2 | $184M | Buy |
2,357,349
+792,349
| +51% | +$59.8M | 0.05% | 448 |
|
|
2017
Q1 | $128M | Buy |
1,565,000
+220,425
| +16% | +$17.3M | 0.03% | 610 |
|
|
2016
Q4 | $96.8M | Sell |
1,344,575
-629,769
| -32% | -$45.5M | 0.03% | 797 |
|
|
2016
Q3 | $153M | Buy |
1,974,344
+48,237
| +3% | +$3.9M | 0.05% | 462 |
|
|
2016
Q2 | $150M | Buy |
1,926,107
+18,140
| +1% | +$1.45M | 0.05% | 460 |
|
|
2016
Q1 | $156M | Sell |
1,907,967
-1,161,168
| -38% | -$94.4M | 0.05% | 446 |
|
|
2015
Q4 | $274M | Buy |
3,069,135
+1,071,305
| +54% | +$91M | 0.09% | 234 |
|
|
2015
Q3 | $153M | Sell |
1,997,830
-1,582,247
| -44% | -$132M | 0.05% | 418 |
|
|
2015
Q2 | $299M | Sell |
3,580,077
-821,416
| -19% | -$72.5M | 0.09% | 220 |
|
|
2015
Q1 | $397M | Buy |
4,401,493
+895,543
| +26% | +$77.1M | 0.13% | 158 |
|
|
2014
Q4 | $283M | Sell |
3,505,950
-1,090,341
| -24% | -$86.1M | 0.09% | 233 |
|
|
2014
Q3 | $344M | Sell |
4,596,291
-1,419,100
| -24% | -$103M | 0.11% | 171 |
|
|
2014
Q2 | $412M | Buy |
6,015,391
+227,725
| +4% | +$15.5M | 0.13% | 146 |
|
|
2014
Q1 | $405M | Sell |
5,787,666
-4,131
| -0.1% | -$287K | 0.13% | 144 |
|
|
2013
Q4 | $387M | Sell |
5,791,797
-106,777
| -2% | -$6.53M | 0.13% | 154 |
|
|
2013
Q3 | $308M | Buy |
5,898,574
+1,331,269
| +29% | +$67.6M | 0.11% | 174 |
|
|
2013
Q2 | $216M | Buy |
+4,567,305
| New | +$209M | 0.08% | 242 |
|
Other funds holding CAH
VCM
VPM
Goldman Sachs's CAH Position: Q1 2026 in Review
Goldman Sachs increased its Cardinal Health (CAH) stake by 16% in Q1 2026, buying an estimated $68.9M and bringing the position to 2,371,854 shares worth $501M. The position accounts for 0.06% of the portfolio, ranked #348.
Goldman Sachs first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Goldman Sachs held 2,371,854 shares of Cardinal Health worth $501M as of Q1 2026.
- Goldman Sachs bought 320,121 Cardinal Health shares in Q1 2026, an estimated $68.9M.
- Cardinal Health made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #348 holding.
- Goldman Sachs first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.